Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations.

Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann Rheum Dis. 2015 Jan; 74(1):190-5.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.